Flash ReportWalgreens to Acquire Rite Aid in $17.2 Billion Deal Coresight Research October 28, 2015 Executive Summary Tuesday, Oct. 27, after the market close, Walgreens Boots Alliance announced an agreement to acquire smaller drugstore chain Rite Aid for $9.4 billion in cash, offering $9 per share in cash, which represents a 48% premium to Rite Aid’s closing price of $6.08 on Monday.Including debt, the deal is valued at $17.2 billion, the company said. The deal would bring together the #1 and #3 retail pharmacy companies, creating a pharmacy giant with over 13,000 stores and more than $67.1 billion in combined revenue, according toDrug Store News’s Annual PoweRx Industry Rankings. The combined company would have an especially strong presence in California and New York. The combination is expected to realizecost synergies of at least $1 billion annually. The boards of both companies have approved the transaction, which must receive Hart-‐Scott-‐Rodino approval and is expected to close during the second half of calendar 2016. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: Sector Focus: Off-Price Shopping—Data GraphicTrends and Predictions for 2025 with Updates from CES and NRF: Premium Subscriber Call, January 2025Financial Sentiment Falls to 14-Month Low Ahead of Reciprocal Tariffs, But Policy Measures Aim to Stabilize Economy: China Consumer Survey InsightsUS Department Stores—Real Estate Insights: The Strategic Real Estate Reset from Flagships to Footprint